Evaluation of a Protocol using Intranasal Fentanyl for Treatment of Acute Pain Crisis in Sickle Cell Patients in the Emergency Department. The SATISFI - Sickle Cell Analgesic Treatment with IN Fentanyl Solution for Fast Track Intervention - Study
CPS ePoster Library. Trottier E. 06/01/17; 176590; 29
Dr. Evelyne Trottier
Dr. Evelyne Trottier
Login now to access Regular content available to all registered users.
Rate & Comment (0)

Background: Sickle cell vaso-occlusive crisis (VOC) is one of the most frequent causes of emergency visit and admission in children with this condition. Intranasal (IN) fentanyl has been used increasingly for pain treatment in the emergency department (ED), including for patient with sickle cell disease (SCD).

Objectives: We aim to evaluate whether the use of a new pain management pathway using IN fentanyl from triage as first line therapy for patient with SCD in VOC will lead to improved care of SCD, translated by a decrease in time to first opiate dose, aiming to meet quality of care indicators. We also aim to prospectively evaluate patient and parent satisfaction with the use of IN Fentanyl.

Methods: Retrospective chart review of patients with SCD who presented to the ED with VOC, in the period pre (Jan - June 2014) and post (Oct - June 2016) implementation of the protocol. Patients in pre received oral or intravenous (IV) opiates as per previous management pathway. Patients in post received IN fentanyl if their pain was moderate-to-severe. Time to first opiate was evaluated pre and post implementation. Patient and parent satisfaction questionnaires were filled prospectively if patient presented during research nurse working hours, and median scores were calculated.

Results: Over the two periods, a total of 107 ED patients (56 pre, 51 post) were included respectively, and 14/51 patients filled out the satisfaction questionnaire. There was a significant difference of -45.8 min (95% CI -61.1, -31.9) in the opiate administration time, now meeting quality of care indicators. There was a significant increase of 45.7% (95% CI 29.0, 59.0) in the use of pain scales at triage evaluation. There was an increase in the number of patient treated with a non-IV opiate as 1st opiate dose: a difference of 43.8% (95% CI 26.7, 57.4). There was no difference in the number of patients without IV treatment: a difference of 15.8 (95% CI -1.4, 32.1). There was no difference in the hospitalization rates: a difference of 12.6 (95% CI -6.2, 30.1. Patient and parent satisfaction with IN treatment was 3.5/5 and 2/5 for the 14 patients evaluated prospectively.

Conclusion: This study validates the use of our protocol using IN fentanyl for the treatment of VOC in the ED by significantly reducing the time to 1st opiate dose. However, our protocol did not decrease the number of IVs.

    This eLearning portal is powered by:
    This eLearning portal is powered by MULTIEPORTAL
Anonymous User Privacy Preferences

Strictly Necessary Cookies (Always Active)

MULTILEARNING platforms and tools hereinafter referred as “MLG SOFTWARE” are provided to you as pure educational platforms/services requiring cookies to operate. In the case of the MLG SOFTWARE, cookies are essential for the Platform to function properly for the provision of education. If these cookies are disabled, a large subset of the functionality provided by the Platform will either be unavailable or cease to work as expected. The MLG SOFTWARE do not capture non-essential activities such as menu items and listings you click on or pages viewed.

Performance Cookies

Performance cookies are used to analyse how visitors use a website in order to provide a better user experience.

Save Settings